Pakistan clears pharma group but puts industry on notice

Pakistan’s competition watchdog has set aside a prima facie finding that a pharmaceutical organisation violated cartel rules, but warned the entire sector against engaging in anticompetitive behaviour.


Get unlimited access to all Global Competition Review content